Skip to Content
Developmental Therapeutics Program (DTP)
Contact DTP
Show menu
Search this site
Last Updated: 01/16/24

Drug Synthesis and Chemistry Branch (DSCB)

The Drug Synthesis and Chemistry Branch is responsible for the following activities in support of the discovery and development of novel anti-cancer agents:

  1. Worldwide scientific liaison activities with universities and industries to stimulate the submission of a wide variety of synthetic compounds, and pure natural products for in vitro anti-cancer screening
  2. Management of the acquisition, synthesis, storage, inventory, documentation, and distribution of chemical samples for research purposes to NIH and external investigators
  3. Acquisition of pre-clinical and clinical anti-cancer small-molecule chemotherapeutics for evaluation in the NCI-60 cell-line screen
  4. Synthetic and medicinal chemistry resource and expertise in support of NExT development and discovery projects.

Organization

Name Position Email
Stephen L. White, Ph.D. Acting Branch Chief whitesl@mail.nih.gov
Omar D. Lopez, Ph.D. Chemist omar.lopez@nih.gov
David C. McCutcheon, Ph.D. Chemist dave.mccutcheon@nih.gov
John D. Williams, Ph.D. Chemist john.williams4@nih.gov
Donn G. Wishka Chemist donn.wishka@nih.gov

Mailing Address:

Dr. Stephen L. White, Acting Branch Chief
National Cancer Institute
DTP/DSCB
9609 Medical Center Drive
Rm 4W128/MSC 9734
Bethesda, MD 20892

Express Mail and Courier Address:

Dr. Stephen L. White, Acting Branch Chief
National Cancer Institute
DTP/DSCB
9609 Medical Center Drive
Rm 4W128/MSC 9734
Bethesda, MD 208502
Email: ncidtpinfo@mail.nih.gov

About the Acting Branch Chief

Dr. Stephen L. White currently serves as the Acting Branch Chief of the Drug Synthesis & Chemistry Branch (DSCB), Developmental Therapeutics Program (DTP) at the National Cancer Institute (NCI). Dr. White joined the NCI in 2007. During his tenure, he has been tasked with various multi-functional leadership responsibilities within the Branch that have primarily focused on management of the NCI Chemotherapeutics Agents Repository (NCI-CAR). More…